http://www.cancergenetics.com
Cancer Genetics, Inc. Company Intro
Cancer Genetics, a leader in drug discovery and immuno-oncology services, is enhancing the development of advanced therapies in precision medicine.
Industry
Healthcare
Cancer Genetics, Inc. Headquaters
201 Route 17 North
Rutherford,07070
United States
Cancer Genetics, Inc. Share price
14 Sep 2022 08:53 GMT
$0
0.0 (0 %)
Cancer Genetics, Inc. Market cap
$
WMC RANKING
2023
Cancer Genetics, Inc. # 186
BiotechnologyLatest Cancer Genetics, Inc. News
26 Mar 2023
NeoGenomics (NASDAQ:NEO) Stock Price Down 4.9%
NeoGenomics, Inc is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical...
26 Mar 2023
NeoGenomics (NASDAQ:NEO) Stock Price Down 4.9%
NeoGenomics, Inc is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical...
26 Mar 2023
NeoGenomics (NASDAQ:NEO) Stock Price Down 4.9%
NeoGenomics, Inc is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical...
WMC Market Score
WMC Market to Revenue Score
Cancer Genetics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Cancer Genetics, Inc. | USD | $6,909 | $6,224 | $-3,270 | $ | 186 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Cancer Genetics, Inc. Social Followers vs Top 4 Industry Competitors
Cancer Genetics, Inc. Post vs Top 4 Industry Competitors
Cancer Genetics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Cancer Genetics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Cancer Genetics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Cancer Genetics, Inc. | 0.11 | 5.46 | 0 | 0 | 0 | 0 | 2.46 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 22 | 0 | 0 | 9.75 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 43.17 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
